Stress, cytokine patterns and susceptibility to disease

被引:85
作者
Elenkov, IJ
Chrousos, GP
机构
[1] NICHD, Pediat Endocrinol Sect, PRDEB, NIH, Bethesda, MD 20892 USA
[2] NIAMSD, Inflammatory Joint Dis Sect, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA
关键词
stress; cytokines; Th1/Th2; cells; interleukin-12; interleukin-10; inflammation; autoimmunity; rheumatoid arthritis;
D O I
10.1053/beem.1999.0045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent evidence indicates that glucocorticoids and catecholamines, the end-products of the stress system, and histamine, a product of activated mast cells, might selectively suppress cellular immunity, and favour humoral immune responses. This is mediated by a differential effect of stress hormones and histamine, on T helper I (Th1)/Th2 patterns and type I/type 2-cytokine production. Thus, systemically, stress might induce a Th2 shift, while, locally, under certain conditions, it might induce pro-inflammatory activities through neural activation of the peripheral corticotropin-releasing factor-mast cell-histamine axis. Through the above mechanisms, stress may influence the onset and/or course of infectious, autoimmune/ inflammatory, allergic and neoplastic diseases.
引用
收藏
页码:583 / 595
页数:13
相关论文
共 54 条
[31]   Different modulation by histamine of IL-4 and interferon-gamma (IFN-gamma) release according to the phenotype of human ThO, Th1 and Th2 clones [J].
Lagier, B ;
Lebel, B ;
Bousquet, J ;
Pene, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 108 (03) :545-551
[32]   Can stress cause disease? Revisiting the tuberculosis research of Thomas Holmes, 1949-1961 [J].
Lerner, BH .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (07) :673-680
[33]  
Li TL, 1997, ANTICANCER RES, V17, P4259
[34]  
MASSUMOTO S, 1995, LANCET, V346, P115
[35]   The expanding universe of T-cell subsets: Th1, Th2 and more [J].
Mosmann, TR ;
Sad, S .
IMMUNOLOGY TODAY, 1996, 17 (03) :138-146
[36]  
OSULLIVAN ST, 1995, ANN SURG, V222, P482
[37]   beta(2)-agonists prevent Th1 development by selective inhibition of interleukin 12 [J].
PaninaBordignon, P ;
Mazzeo, D ;
DiLucia, P ;
DAmbrosio, D ;
Lang, R ;
Fabbri, L ;
Self, C ;
Sinigaglia, F .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1513-1519
[38]  
Ramirez F, 1996, J IMMUNOL, V156, P2406
[39]   Psychoneuroimmunology of autoimmune disorders [J].
Rogers, MP ;
Fozdar, M .
ADVANCES IN NEUROIMMUNOLOGY, 1996, 6 (02) :169-177
[40]  
Sanders VM, 1997, J IMMUNOL, V158, P4200